ArticleKorean journal of urology2015

Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy.

Tomokazu Sazuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.